# Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease.

> **NCT06237712** · NA · ACTIVE_NOT_RECRUITING · sponsor: **Erasmus Medical Center** · enrollment: 31 (estimated)

## Conditions studied

- Metabolic Acidosis
- CKD
- Electrolyte and Fluid Balance Conditions

## Interventions

- **DIETARY_SUPPLEMENT:** Dietary supplement consisting of 40 mmol/daily of potassium chloride
- **DIETARY_SUPPLEMENT:** Dietary supplement consisting of 40 mmol/daily of potassium gluconate
- **DIETARY_SUPPLEMENT:** Dietary supplement consisting of 40 mmol/daily of potassium bicarbonate
- **DIETARY_SUPPLEMENT:** Dietary supplement consisting of 40 mmol/daily of sodium chloride
- **DIETARY_SUPPLEMENT:** Dietary supplement consisting of 40 mmol/daily of sodium bicarbonate
- **DIETARY_SUPPLEMENT:** Placebo caps

## Key facts

- **NCT ID:** NCT06237712
- **Lead sponsor:** Erasmus Medical Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-01-26
- **Primary completion:** 2025-03-21
- **Final completion:** 2026-07
- **Target enrollment:** 31 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06237712

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06237712, "Explorative Study to Investigate the Acid-base Response to Sodium and Potassium Salts in Patients With Chronic Kidney Disease.". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06237712. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*